Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony’s management team will participate in the following upcoming investor conferences:
https://mma.prnewswire.com/media/1081494/Harmony_Biosciences_Logo.jpg
Citi’s 2024 Global Healthcare Conference
— Location:Miami
— Tuesday, December 3, 2024
Piper Sandler 36th Annual Healthcare Conference
— Location:New York City
— Fireside Chat:Wednesday, December 4, 2024, at8:30 a.m., ET
A webcast of the fireside chat will be available on the investor page of Harmony’s website at https://ir.harmonybiosciences.com/.
AboutHarmony BiosciencesHarmony Biosciencesis a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked,Harmony Biosciencesis nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established byParagon Biosciences, LLC, in 2017 and headquartered inPlymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visitwww.harmonybiosciences.com.
Harmony Biosciences Investor Contact:Brennan Doyle484-539-9700bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:Cate McCanless202-641-6086cmccanless@harmonybiosciences.com
https://c212.net/c/img/favicon.png?sn=DC62793&sd=2024-11-21
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302312218.html
SOURCE Harmony Biosciences
https://rt.newswire.ca/rt.gif?NewsItemId=DC62793&Transmission_Id=202411210805PR_NEWS_USPR_____DC62793&DateId=20241121
COMTEX_460035625/1005/2024-11-21T08:05:25